ZA852564B - Live purified marek's disease vaccine - Google Patents

Live purified marek's disease vaccine

Info

Publication number
ZA852564B
ZA852564B ZA852564A ZA852564A ZA852564B ZA 852564 B ZA852564 B ZA 852564B ZA 852564 A ZA852564 A ZA 852564A ZA 852564 A ZA852564 A ZA 852564A ZA 852564 B ZA852564 B ZA 852564B
Authority
ZA
South Africa
Prior art keywords
marek
disease
virus
mdv
monovalent
Prior art date
Application number
ZA852564A
Other languages
English (en)
Inventor
Gerben Foppe De Boer
Original Assignee
Gerben Foppe De Boer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gerben Foppe De Boer filed Critical Gerben Foppe De Boer
Publication of ZA852564B publication Critical patent/ZA852564B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/255—Marek's disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
ZA852564A 1984-04-09 1985-04-04 Live purified marek's disease vaccine ZA852564B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8401120A NL8401120A (nl) 1984-04-09 1984-04-09 Viruspreparaat, waarmee gevaccineerd kan worden tegen de ziekte van marek.

Publications (1)

Publication Number Publication Date
ZA852564B true ZA852564B (en) 1985-11-27

Family

ID=19843774

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA852564A ZA852564B (en) 1984-04-09 1985-04-04 Live purified marek's disease vaccine

Country Status (17)

Country Link
US (1) US4673572A (de)
EP (1) EP0159743B1 (de)
JP (1) JPS6123A (de)
AT (1) ATE56364T1 (de)
AU (1) AU574164B2 (de)
CA (1) CA1251397A (de)
DD (1) DD232822A5 (de)
DE (1) DE3579617D1 (de)
ES (1) ES8605680A1 (de)
HU (1) HU194496B (de)
IL (1) IL74809A (de)
IN (1) IN163229B (de)
MX (1) MX7718E (de)
NL (1) NL8401120A (de)
WO (1) WO1985004588A1 (de)
YU (1) YU44687B (de)
ZA (1) ZA852564B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4456101A (en) * 1980-11-08 1984-06-26 Honda Giken Kogyo Kabushiki Kaisha Vehicular brake operating system
JP2508625B2 (ja) * 1985-08-30 1996-06-19 ソニー株式会社 半導体レ−ザ−
FR2598596B1 (fr) * 1986-05-15 1990-10-19 Sanofi Elf Bio Ind Procede de traitement du lait en vue de l'obtention de fromages
US5849299A (en) * 1991-06-28 1998-12-15 The United States Of America As Represented By The Secretary Of Agriculture Attenuated revertant serotype 1 marek's disease vaccine
WO1993023078A1 (en) * 1992-05-19 1993-11-25 Viktoria Alexeevna Lukina Vaccine for prophylaxis of marek disease of birds and method of its preparation
IL114501A (en) * 1994-07-14 1999-08-17 Akzo Nobel Nv Marek's disease virus vaccine
EP0703294A1 (de) * 1994-07-14 1996-03-27 Akzo Nobel N.V. Virusimpfstoff gegen Mareksche Krankheit
EP0748867A1 (de) * 1995-06-12 1996-12-18 Duphar International Research B.V Marek-Krankheit Vakzine
US5989805A (en) * 1995-10-27 1999-11-23 Board Of Trustees Operating Michigan State University Immortal avian cell line to grow avian and animal viruses to produce vaccines
WO1997046103A1 (en) * 1996-06-04 1997-12-11 University Of Georgia Research Foundation, Inc. Modified live avian polyomavirus vaccine in psittacine birds
EP1038952A3 (de) * 1998-12-09 2001-06-27 Pfizer Products Inc. Verfahren zur Herstellung von Mareks Disease Virus (MDV) unter Verwendung von kontinuierlichen Vogelzellinien
AP2014007955A0 (en) 2012-03-22 2014-09-30 Merial Ltd Modified marek's disease virus, and vaccines made therefrom

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1292803A (en) * 1968-11-18 1972-10-11 Nat Res Dev Improvements relating to the production of antigens
US3642574A (en) * 1970-04-29 1972-02-15 Us Agriculture Method for producing vaccine for immunization of poultry against marek{3 s disease
US3783098A (en) * 1971-08-10 1974-01-01 Cornell Res Foundation Inc Highly potent,viable and stable cellfree virus preparations from cells infected with cell-associated viruses and method for obtaining the same
US4160024A (en) * 1978-05-01 1979-07-03 Cornell Research Foundation, Inc. Marek's disease vaccine

Also Published As

Publication number Publication date
IL74809A (en) 1990-09-17
EP0159743A1 (de) 1985-10-30
IL74809A0 (en) 1985-07-31
YU59985A (en) 1988-06-30
HUT38542A (en) 1986-06-30
IN163229B (de) 1988-08-27
NL8401120A (nl) 1985-11-01
YU44687B (en) 1990-12-31
ATE56364T1 (de) 1990-09-15
ES541930A0 (es) 1986-04-16
DE3579617D1 (de) 1990-10-18
JPS6123A (ja) 1986-01-06
ES8605680A1 (es) 1986-04-16
CA1251397A (en) 1989-03-21
EP0159743B1 (de) 1990-09-12
WO1985004588A1 (en) 1985-10-24
US4673572A (en) 1987-06-16
AU4156185A (en) 1985-11-01
MX7718E (es) 1990-10-10
JPH0317808B2 (de) 1991-03-11
DD232822A5 (de) 1986-02-12
HU194496B (en) 1988-02-29
AU574164B2 (en) 1988-06-30

Similar Documents

Publication Publication Date Title
Takahashi et al. Transformation of hamster embryo and human embryo cells by temperature sensitive mutants of herpes simplex virus type 2
ZA852564B (en) Live purified marek's disease vaccine
Powell Immunity to Marek's disease induced by glutaraldehyde-treated cells of Marek's disease lymphoblastoid cell lines
ES8502871A1 (es) Procedimiento de obtencion de vacunas de bronquitis infecciosa para aves de corral
EP0125245B1 (de) Kultivierung von hämorrhagische enteritis hervorrufenden viren in truthahn-gewebe-zellkulturen
ALLEN et al. Role of coexpression of IL-2 and herpes simplex virus proteins in recombinant vaccinia virus vectors on levels of induced immunity
ES8200227A1 (es) Procedimiento de obtencion de vacunas de bronquitis in- fecciosa para aves de corral
EP0775743A2 (de) Hühnchenzelllinie, die mit Mareks Krankheitsviren infiziert ist
CA1292689C (en) Live vaccine for contagious disease of chickens
US5686287A (en) Marek's disease virus vaccine
CA2222482A1 (en) Non-virulent mycoplasma synoviae and vaccine thereof
US4895718A (en) Serotype 2 Marek's disease vaccine
HU914111D0 (en) Cell-less marek-type virus vaccine
Carmichael et al. Small-plaque variant of canine herpesvirus with reduced pathogenicity for newborn pups
CA2112225C (en) Attenuated revertant serotype 1 marek's disease vaccine
US4213965A (en) Small-plaque variant canine herpesvirus vaccine
US5565202A (en) Low enhancement serotype 2 vaccine for marek's disease
Eisenstein et al. Salmonella vaccines: Protection by endotoxin protein and lipopolysaccharide in two different mouse strains.
ES2074965A1 (es) Virus mutante recombinante de rinotraqueitis infecciosa bovina y vacunas que lo contienen.
Jeffries et al. Atypical menaquinone pattern in a strain of Staphylococcus aureus
EP0703294A1 (de) Virusimpfstoff gegen Mareksche Krankheit
CA1289881C (en) Vaccine against herpes simplex
RO96364B1 (ro) PROCEDEU DE PREPARARE A UNUI VACCIN VIU PURIFICAT îMPOTRIVA BOLII LUI MAREK